This will be a randomized control trial to estimate the efficacy of two doses (80 mg versus 160 mg) of aspirin for prevention of preeclampsia in High-Risk Pregnant Women identified in the first trimester to be at high risk.
Age
18–45
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Pregnant women presenting prior to 17+0 weeks' gestation.
Moderate to high risk of preeclampsia.
One or more of the following: previous history of preeclampsia, antiphospholipid antibodies, pre-existing diabetes, pre-existing hypertension, pre-existing renal disease, autoimmune disease, nulliparity, family history of preeclampsia, elevated BMI \> 25, and maternal age \<20 or \>35.
